These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7556317)

  • 1. Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole.
    Simma B; Meister B; Deutsch J; Sperl W; Fend F; Ofner D; Margreiter R; Vogel W
    Eur J Pediatr; 1995 Jul; 154(7):530-3. PubMed ID: 7556317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful extracorporeal liver dialysis for the treatment of trimethoprim-sulfamethoxazole-induced fulminant hepatic failure.
    Ng CT; Tan CK; Oh CC; Chang JP
    Singapore Med J; 2013 May; 54(5):e113-6. PubMed ID: 23716163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute fulminant hepatic failure in a woman treated with phenytoin and trimethoprim-sulfamethoxazole.
    Ilario MJ; Ruiz JE; Axiotis CA
    Arch Pathol Lab Med; 2000 Dec; 124(12):1800-3. PubMed ID: 11100060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful orthotopic liver transplantation after trimethoprim-sulfamethoxazole associated fulminant liver failure.
    Zaman F; Ye G; Abreo KD; Latif S; Zibari GB
    Clin Transplant; 2003 Oct; 17(5):461-4. PubMed ID: 14703931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
    Fox BC; Sollinger HW; Belzer FO; Maki DG
    Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
    Guibert J; Capron MH
    J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible voltage-dependent distal renal tubular acidosis in a patient receiving standard doses of trimethoprim-sulphamethoxazole.
    Lin SH; Kuo AA; Yu FC; Lin YF
    Nephrol Dial Transplant; 1997 May; 12(5):1031-3. PubMed ID: 9175064
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver transplantation for disulfiram-induced fulminant hepatic failure.
    Mohanty SR; LaBrecque DR; Mitros FA; Layden TJ
    J Clin Gastroenterol; 2004 Mar; 38(3):292-5. PubMed ID: 15128079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comeback of trimethoprim in France.
    Caron F; Wehrle V; Etienne M
    Med Mal Infect; 2017 Jun; 47(4):253-260. PubMed ID: 28043762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
    Bell TL; Foster JN; Townsend ML
    Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gilfillan EC; Pelak BA; Gadebusch HH
    J Antimicrob Chemother; 1985 Dec; 16(6):735-41. PubMed ID: 3912365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of trimethoprim-sulphamethoxazole in two-day-old foals after a single intravenous injection.
    Brown MP; McCartney JH; Gronwall R; Houston AE
    Equine Vet J; 1990 Jan; 22(1):51-3. PubMed ID: 2298191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifaprim in urinary tract infection: a comparison with co-trimoxazole.
    Kosmidis J; Giamarellou H; Papadakis M; Eliades E; Daikos GK
    J Antimicrob Chemother; 1983 Mar; 11(3):239-44. PubMed ID: 6601648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
    Hagiya H
    J Chemother; 2015 Feb; 27(2):124-5. PubMed ID: 25248022
    [No Abstract]   [Full Text] [Related]  

  • 16. A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus.
    Kelly JW; Dooley DP; Lattuada CP; Smith CE
    Clin Infect Dis; 1992 May; 14(5):1034-9. PubMed ID: 1600003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
    Huntsberry AM; Linnebur SA; Vejar M
    Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.
    Carr A; Penny R; Cooper DA
    AIDS; 1993 Jan; 7(1):65-71. PubMed ID: 8442919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
    J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A suspected case of trimethoprim-sulfamethoxazole-induced loss of fingernails and toenails.
    Slaughenhoupt BL; Adeagbo S; Van Savage JG
    Pediatr Infect Dis J; 1999 Jan; 18(1):76-7. PubMed ID: 9951991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.